SGLT2 inhibitor — used for diabetes, heart failure, and CKD
Generic name: empagliflozin
US Retail Price
$550–$650/month
With copay card: As low as $10/month (commercially insured)
Manufacturer
Boehringer Ingelheim / Eli Lilly
Used For
Type 2 diabetes, heart failure (HFrEF and HFpEF), chronic kidney disease (CKD)
Generic empagliflozin is not yet available in the US. Jardiance patent protection is expected to last until approximately 2025–2027. International pharmacies offer the most significant savings for Medicare patients.
Boehringer Ingelheim offers a savings card that can reduce Jardiance to as low as $10/month for commercially insured patients. Not valid for Medicare/Medicaid.
Apply for Jardiance Savings CardVerified international pharmacies sell Jardiance (empagliflozin) for $60–$120/month — far less than US retail. This is often the best option for Medicare patients.
Compare International PricesBoehringer Ingelheim and Eli Lilly offer patient assistance for those who meet income requirements. Search NeedyMeds for the Jardiance PAP application.
Search Jardiance PAP on NeedyMedsGoodRx coupons can reduce Jardiance costs at US pharmacies. Most useful when the GoodRx price is lower than your insurance copay.
Check GoodRx PriceLooking for another medication?
The Med Map covers all 8 categories of savings options for hundreds of drugs.
Back to The Med Map